Release RSS (2.0) http://www.cision.com Release RSS(2.0) provided by Cision Mon, 11 May 2026 08:44:15 +0200 Release RSS (2.0) 120 32 http://www.cision.com http://feed.ne.cision.com/client/_images/CisionLogoSmall.gif Share options granted Share options granted]]> Fri, 10 Jan 2020 13:40:00 +0100 https://publish.ne.cision.com/v2.0/Release/GetDetailInLegacyFormat/162B60950DE77233 https://publish.ne.cision.com/v2.0/Release/GetDetailInLegacyFormat/162B60950DE77233 Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The options are granted without consideration.  The series A options are granted vest over a 3 year period, with 1/3 after 12 months, 1/3 after 24 months and the last third after 36 months. The series A option shares have a 12 month lock-up period tied to them. Options that have not been exercised will lapse 3.5 years after grant date. The series B options are granted vest on the date of the option agreement. The series B option shares have a 24 month lock-up period tied to them. Options that have not been exercised will lapse as of January 1 2021. The strike price for the options is NOK 11.09 and calculated as the average price the last 10 trading days before signing of the option agreement. This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act. Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The options are granted without consideration. 

The series A options are granted vest over a 3 year period, with 1/3 after 12 months, 1/3 after 24 months and the last third after 36 months. The series A option shares have a 12 month lock-up period tied to them. Options that have not been exercised will lapse 3.5 years after grant date.

The series B options are granted vest on the date of the option agreement. The series B option shares have a 24 month lock-up period tied to them. Options that have not been exercised will lapse as of January 1 2021.

The strike price for the options is NOK 11.09 and calculated as the average price the last 10 trading days before signing of the option agreement.

This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.

]]> PRM Pressrelease en Observe Medical ASA Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The options are granted without consideration. 

The series A options are granted vest over a 3 year period, with 1/3 after 12 months, 1/3 after 24 months and the last third after 36 months. The series A option shares have a 12 month lock-up period tied to them. Options that have not been exercised will lapse 3.5 years after grant date.

The series B options are granted vest on the date of the option agreement. The series B option shares have a 24 month lock-up period tied to them. Options that have not been exercised will lapse as of January 1 2021.

The strike price for the options is NOK 11.09 and calculated as the average price the last 10 trading days before signing of the option agreement.

This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.

]]> Press release in html format MAIN https://publish.ne.cision.com release.html text/html 4711 true